Filing Details
- Accession Number:
- 0001213900-24-101610
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-22 16:16:10
- Reporting Period:
- 2024-11-20
- Accepted Time:
- 2024-11-22 16:16:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1514183 | Silo Pharma Inc. | SILO | Pharmaceutical Preparations (2834) | 462137136 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1569077 | Eric Weisblum | C/O Silo Pharma, Inc. 677 N. Washington Boulevard Sarasota FL 34236 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-20 | 2,500 | $0.95 | 182,932 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-11-22 | 2,500 | $0.90 | 185,432 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |